GRESPO AB
Grespo is a young biomedical company specialized in preventing and treating diseases of the Central Nervous System (CNS), based on research on the effect of the 2-oxoglutarate substance (2-OX) in the body. A number of studies have demonstrated effects of 2-OX treatment in several disease fields. Grespo’s main target is the central nervous system (CNS) and diseases like Alzheimer and Parkinson.
GRESPO AB
Industry:
Biotechnology Pharmaceutical Therapeutics
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.grespo.se
Status:
Active
Technology used in webpage:
Viewport Meta SSL By Default LetsEncrypt Apache Euro IPv6 Varnish Mobile Optimized One.com DNS One.com Website Builder
Similar Organizations
Nyken Theraputics
Nyken is a biopharmaceutical company
Synphora AB
Synphora AB is a clinical-stage biopharmaceutical company
Official Site Inspections
http://www.grespo.se
- Host name: webcluster1.webpod12-cph3.one.com
- IP address: 46.30.213.4
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Grespo AB"
About | grespo.se
A number of studies have demonstrated effects of 2-OX treatment in several disease fields. Grespo’s main target is the central nervous system (CNS) and diseases like Alzheimer and Parkinson. Grespo is on a quest to create …See details»
Grespo AB - Crunchbase Company Profile & Funding
Grespo is a young biomedical company specialized in preventing and treating diseases of the Central Nervous System (CNS), based on research on the …See details»
Grespo Company Profile - Office Locations, Competitors, Revenue …
Grespo is a biomedical company with a focus on the prevention and cure of neurodegenerative diseases such as MCI (Mild Cognitive Impairment) and Alzheimer. It is active in research on …See details»
Grespo AB Company Profile | Lund, Skåne, Sweden | Competitors ...
Find company research, competitor information, contact details & financial data for Grespo AB of Lund, Skåne. Get the latest business insights from Dun & Bradstreet.See details»
Grespo AB - Drug pipelines, Patents, Clinical trials - Synapse
Explore Grespo AB with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, Drug:GRE …See details»
Grespo AB - VentureRadar
Grespo is a Swedish biomedical company with a focus on prevention and cure of neurodegenerative diseases such as MCI (Mild Cognitive Impairment) and Alzheimer. …See details»
Grespo AB | Aktiebolag | Info & Löner - Bolagsfakta
Grespo AB – Org.nummer: 556710-0275. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.See details»
Grespo AB:Company Profile & Technical Research,Competitor …
Grespo AB is a company that provides Allopregnanolone, Central nervous system, Pharmacy and Therapeutics and more. Grespo AB is headquartered in Sweden . Grespo AB has a total of 19 …See details»
Grespo AB - Företagsinformation - allabolag.se
Grespo AB,556710-0275 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för Grespo AB. Sök ... Bolagshändelser; Grespo AB. Org.nr: 556710-0275 Bevaka företag …See details»
Grespo AB - Company Profiles - BCIQ
For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, …See details»
grespo.se
Grespo is a Swedish biomedical company with a focus on prevention and cure of neurodegenerative diseases such as MCI (Mild Cognitive Impairment) and Alzheimer. Product …See details»
Grespo AB | VentureRadar
Grespo is a Swedish biomedical company with a focus on prevention and cure of neurodegenerative diseases such as MCI (Mild Cognitive Impairment) and Alzheimer. …See details»
Grespo AB i Lund (556710-0275) - Merinfo.se
Grespo AB (556710-0275). Se adress, telefonnummer, omsättning, styrelse, nyckeltal, m.m. Logga in. ... Jämför din lön - Som medlem kan du se och jämföra din inkomst med andra i …See details»
Grespo AB - 556710-0275 - Lund - Se Nyckeltal, Befattningar med …
Allabolag.se ger dig företagsinformation om Grespo AB, 556710-0275. Hitta adress på karta, kontaktinfo, nyckeltal och befattningar. Välkommen till nya Allabolag! ... Grespo AB. Org.nr …See details»
GRE-213 - Drug Targets, Indications, Patents - Synapse
GRE-213, Initially developed by Grespo AB, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases, Active Indication: Central Nervous System …See details»
Investors | grespo.se
General Meeting 2024. will be held 17.00 CET on June 28th at the company's office in Lund. Notice and other material have been sent to the shareholders of record.See details»
GRESPO AB | TREA
Explore innovation relationships and map ideas to the unified knowledge graphSee details»
GRE 213 - AdisInsight - Springer
Grespo is developing GRE 213, a combination of two active ingredients for the treatment of neurodegenerative disorders such as mild cognitive impairment, GRE 213 - AdisInsight Either …See details»
Grespo AB: 药物管线_专利_临床试验_投融营收_最新药物:GRE-213
了解Grespo AB公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:神经系统疾病，技术平台:小分子化药，药物:GRE-213。 数据. 资源. 版本对比. 免费注册. 预约演示. 免费注册. 更 …See details»
GRESPO, s.r.o. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GRESPO, s.r.o. of Veličná, Žilinský kraj. Get the latest business insights from Dun & Bradstreet.See details»